Supplementary Figures 1-4
Supplementary Figure 1| Inhibition of SEA -induced cytokine production by T5910047 in primary culture of mouse spleen cells. Spleen cells (1×10 6 ) from C57/BL6 mice were isolated as described elsewhere 9 and cultured for 20 h with SEA (200 ng/ml), LPS (1µg/ml) or SEA+LPS with or without T5910047 (625 µM to 62 µM) treatment. The culture supernatants were collected and measured for cytokine by CBA assay as described in materials and methods. The data presented as pg/ml cytokine production after exposure to (a) SEA, (b) LPS and (c) SEA+LPS.
Supplementary Figure 2| Inhibition of MyD88 dependent but not MyD88-independent
expression of SEAP activity by compounds T5910047, T6167923 and T5996207. HEK 293 stable transfected cells (TLR4-MD2-NF-kB-SEAP) was stimulated with E. coli LPS (1 µg) or poly I: C (10 µg) with or without varying concentrations of the compounds (500 µM to 0.1 µM) respectively. Culture supernatants were tested for SEAP activity. (a) Data presented as SEAP response unit ± SEM. HEK-Blue hTLR3 cells were used to determine a specificity control of the MyD88 inhibitors for real time detection of NF-kB induced SEAP activity after stimulation with poly I:C (10 µg) with or without compound treatment. Real time detection of SEAP response was determined using HEK-Blue detection medium (Invivogen) Quanti-Blue TM by reading the OD at 655 nm. (b) Data presented as OD ± SEM as a measure of SEAP activity. ELISA-based chemiluminescence Trans AM Chemi Kit (Active Motif) and antibodies was used to detect NFkB activation using NF-kB recognition epitope on p50 and p65 in cell extracts of HEK-Blue hTLR3 cells stimulated with poly I: C in the presence and absence of inhibitors. Assays were performed in duplicate to measure NF-kB by using equal amounts of protein (4 µg) from the cell extracts as described elsewhere 7 . (C) Data presented as a relative luminescence unit (RLU) as a measure of NF-kB activation of p50 and p65 subunit, quantified using luminescence measurement.
Table1| 2 nd generation compounds (PubChem database) were tested at varying concentrations (125 µM, 50 µM and5 µM) in primary culture of human PBMCs exposed to SEB and measured cytokines in culture supernatants by MSD assay (raw data). Supplementary Figure 3| IC 50 of 2 nd generation compounds tested in primary cultures of human PBMCs exposed to SEB. PBMCs (1×10 6 ) from a normal donor was cultured for 20 h with SEB (200 ng/ml) with or without 10 different compounds [(2 nd generation) identified from PubChem database that were >80% similar to T5910047] using varying concentrations (125 µM to 5 µM). The culture supernatants were collected and measured for cytokine by MSD assay (Table 1) as described in the Experimental section. The compound identity (compound ID and ZN ID), Molecular weight,% structural similarity, and X LogP values and IC 50 calculated as the concentration required for SEB-induced inhibition of cytokine production in PBMCs by 50% relative to the control are shown in Table 2 . Data presented as IC 50 .
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Supplementary Figure 4| Cytokine inhibition by 2 nd generation compounds T6167923
and T5996207 tested with exposure to SEB or SEA in primary cultures of human PBMCs isolated from multiple donors. PBMCs (1×10 6 ) from normal donors was cultured for 20 h with SEB (200 ng/ml) with or without varying concentrations (500 µM to 10 µM) of T6167923 and T5996207. The culture supernatants were collected and measured for cytokine (pg/ml) by MSD assay as described in the experimental section. The data are presented as IC 50 values, calculated as the concentration required for SEB-induced inhibition of cytokine production in PBMCs by 50% relative to the control. 
